期刊文献+

西地那非联合十一酸睾酮治疗糖尿病性勃起功能障碍的安全性有效性多中心研究 被引量:9

A Multicenter Research of Sildenafil Combined with Testosterone Undecanoate for Treatment of Erectile Dysfunction with Diabetes
原文传递
导出
摘要 目的观察西地那非联合十一酸睾酮治疗糖尿病患者阴茎勃起障碍的疗效和安全性.方法2009年1月至2011年12月多中心收集广州市番禺区中心医院、上海交通大学医学院附属仁济医院、上海市中医医院泌尿男科门诊糖尿病性勃起功能障碍患者共100例,患者签署知情同意书后,根据国际勃起功能指数表(IIEF-5)进行自我评分.随机分为两组:A组:50例,控制血糖常规治疗的基础上服用西地那非(50mg prn)加十一酸睾酮(80mg/Bid);B组:50例,在控制血糖常规治疗的同时给予西地那非治疗,两组均治疗12周.观察两组患者治疗前后的疗效,并记录患者服药后的不良事件以评价其安全性.结果共计82例完成本次研究,其中A组42例、B组40例.两组患者IIEF-5评分在治疗后均显著增加,而A组较B组增加更显著,差异具统计学意义(P〈0.05).治疗后每周性交频率均显著增加,A组较B组增加更明显,差异具统计学意义(P〈0.05).其中A组显效率高达59.5%,有效率为88.1%,明显高于B组(显效率30.00%,有效率55.00%),P〈0.05.A组37例患者性交时阴茎能满意勃起,而B组只有22例患者性交时阴茎能满意勃起;两组均未出现任何不良反应.结论西地那非联合十一酸睾酮治疗糖尿病性勃起功能障碍较单用西地那非可显著改善患者的勃起能力,且安全性好. Objective To study the effects and safety of sildenafil combined with testosterone undecanoate for treatment of Erectile Dysfunction (ED)with Diabetes. Methods A total of 100 ED patients with diabetes from Panyu Central Hospital of Guangzhou, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and Traditional Chinese Medicine Hospital of Shanghai, were recruited in the study. Informed consent was obtained from each patient. They were evaluated by the International Index of Erectile Function Table(IIEF-5) and randomly assigned to two groups. Patients in Group A received sildenafil combined with testosterone undecanoate (80mg/Bid) (n=50), while patients in Group B received sildenafil only (n = 50) for 12 weeks. Both treatments were on the basis of glycemic well control. We assessed the differences of efficacy between two treatments, and recorded the adverse events for safety evaluation. Results Total of 82 patients completed the study, including 42 in Group A and 40 in Group B. Both Groups had significant increases in IIEF scale (P〈0.05). The increase of IIEF scale in Group A was more dramatic than that in Group B (P〈0.05). The obvious effective rate and effective rate of Group A were 59.52% and 88.10% respectively, higher than that of Group B (30.00% and 55.00%), with P value lower than 0.05. No adverse events were noted in two groups. Conclusion Compared to sildenafil therapy only, Sildenafil therapy combined with testosterone undecanoate can improve the sexual function of ED patient with diabetes, having a more satisfactory drug safety.
出处 《中国男科学杂志》 CAS CSCD 北大核心 2013年第4期26-29,共4页 Chinese Journal of Andrology
基金 本课题受上海市科委重大科研计划男性更年期性腺轴功能减退及相关疾病发生机制和诊疗的研究(09DJ1400400)资助
关键词 糖尿病 勃起功能障碍 磷酸二酯酶抑制剂 睾酮 diabetes mellitus erectile dysfunction tphosphodiesterase inhibitors testosterone
  • 相关文献

参考文献9

  • 1Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 2005; 32(4): 379-395.
  • 2Cho NH, Ahn CW, Park JV, etal. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. DiabetMed 2005; 23(2): 198-203.
  • 3Penson DF, Latini DM, Lubeck DP, etal. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent atients results from the exploratory comprehensive evaluation of erectile dysfunction(Ex CEED)database.Diabetes Care 2003; 26(4): 1093-1099.
  • 4冷静,王益鑫,黄旭元,薄隽杰,韩银发,陈斌,戴继灿,江鱼.上海市1582例中老年男子勃起功能障碍流行病学调查[J].中国男科学杂志,2000,14(1):29-31. 被引量:118
  • 5王晓峰.男性睾酮缺乏的诊断和治疗[J].中华男科学杂志,2010,16(4):291-294. 被引量:6
  • 6王雪松,刘珍,安康,宋永胜,崔军,殷波,刘鹏,姚雷.西地那非治疗2型糖尿病患者勃起功能障碍疗效分析[J].中国男科学杂志,2011,25(3):45-47. 被引量:2
  • 7Pu XY, Wang XH, Gao WC, et al. Insulin-like growth factor-1 restores erectile function in aged rate: modulation the integrity of smooth muscle and nitric oxide-cyclic guanosine monophosphate signaling activity. J Sex Meal 2008; 5(6): 1345-1354.
  • 8储继凯,连庆文,申海涛,等.雄激素在ED合并LOH中治疗作用的临床研究.中外健康文摘,2011;8(18):185-186.
  • 9张丹丹,母义明,李江源.迟发性睾丸功能减退症的睾酮补充治疗[J].国际内分泌代谢杂志,2007,27(4):286-288. 被引量:4

二级参考文献40

  • 1中国2型糖尿病勃起功能障碍多中心调查协作组.2型糖尿病患者勃起功能障碍患病率及西地那非的疗效和安全性评价[J].中华内分泌代谢杂志,2005,21(4):348-352. 被引量:36
  • 2何学酉,宋涛,李钢,于明波,王晓雄,洪宝发.小剂量雄激素治疗少弱精子症的临床研究[J].中国男科学杂志,2006,20(7):28-32. 被引量:29
  • 3李江源,李小鹰,李明,张高魁,马芳玲,刘志民,张南雁,孟萍.中国健康男子迟发性睾丸功能减退的症状评价[J].中华男科学杂志,2007,13(4):320-323. 被引量:12
  • 4MCGAVACK TH. The male climacterium. J Am Geriatr Soc, 1955, 3(9) : 639-655.
  • 5Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2006, 91(6): 1995-2010.
  • 6Mohr BA, Guay AT, O'Donnell AB, et al. Normal, bound and nonbound testosterone levels in normally ageing men: Results from the Massachusetts Male Ageing Study. Clin Endocrinol Oxf, 2005, 62(1) : 64-73.
  • 7Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab, 2002, 87(2) : 589-598.
  • 8Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men : Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab, 1991, 73(5) : 1016-1025.
  • 9Mohr BA, Bhasin S, Link CL, et al. The effect of changes in adiposity on testosterone levels in older men: Longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol, 2006, 155(3) : 443-452.
  • 10Rodriguez A, Muller DC, Metter EJ, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab, 2007, 92(9) : 3568-3572.

共引文献126

同被引文献97

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部